Sign in

CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
460571712
Phone
484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 8-K Event Regulation FD disclosure
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Regulation FD disclosure · Other events
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 8-K Event Regulation FD disclosure
  14. 4 Option exercise Director acquired 4,793 shares (option exercise)
  15. 4 Option exercise Director acquired 4,793 shares (option exercise)
  16. 4 Option exercise Director acquired 4,793 shares (option exercise)
  17. 4 Option exercise Director acquired 4,793 shares (option exercise)
  18. 4 Option exercise Director acquired 4,793 shares (option exercise)
  19. 4 Option exercise Director acquired 4,793 shares (option exercise)
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 4 of 44 · 872 filings